Insulin Level, Lipid Profile, and HOMA Index in Lean and Obese Patients with Polycystic Ovary Syndrome

Overview

Journal J Med Life

Specialty General Medicine

Date 2023 Nov 29

PMID 38024834

Authors

Shamim Riadh Mohammed Hussein

Alaa Mohammed Sadiq

Shadan Ali Johar

Alaa Jumaah Manji Nasrawi

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a prevalent endocrinopathy characterized by insulin resistance, hyperinsulinemia, and increased ovarian androgen production. While obesity has been linked to the pathogenesis of PCOS, the condition is also observed in individuals with normal BMI. This cross-sectional study aimed to evaluate the biochemical profile of lean and obese patients with PCOS. Fifty female patients with previously diagnosed PCOS were included in the study, attending the outpatient clinic at AL-Zahraa Teaching Hospital in Al-Najaf between September 2021 and March 2022. Blood samples were collected from each patient to assess insulin levels, lipid profiles, and fasting blood sugar. The results showed a comparable percentage of lean and obese PCOS patients, with a slightly higher proportion of obese individuals. Statistically significant differences were observed in obese patients with higher fasting blood sugar levels, insulin, HDL cholesterol, and triglycerides. Additionally, the HOMA index, an indicator of insulin resistance, was higher in obese individuals. Lean PCOS patients exhibited metabolic, hormonal, and hematopoietic dysregulations comparable to or less pronounced than those affecting the obese phenotype. Regardless of BMI, insulin resistance is part of PCOS and must be treated immediately.

Citing Articles

High-Density Lipoprotein Is Located Alongside Insulin in the Islets of Langerhans of Normal and Rodent Models of Diabetes.

Mohsin S, Elabadlah H, Alotaiba M, AlAmry S, Almehairbi S, Harara M Nutrients. 2024; 16(2).

PMID: 38276551 PMC: 10818677. DOI: 10.3390/nu16020313.

References

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

Gholinezhad M, Gholsorkhtabaramiri M, Esmaeilzadeh S, Ghanbarpour A . Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome. Caspian J Intern Med. 2018; 9(3):260-267. PMC: 6121333. DOI: 10.22088/cjim.9.3.260. View

Kumawat M, Choudhary P, Aggarwal S . Association of Serum Leptin with Anthropometric Indices of Obesity, Blood Lipids, Steroidal Hormones, and Insulin Resistance in Polycystic Ovarian Syndrome. J Hum Reprod Sci. 2021; 14(3):228-233. PMC: 8527077. DOI: 10.4103/jhrs.jhrs_35_21. View

Jamil A, Alalaf S, Al-Tawil N, Al-Shawaf T . A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Reprod Health. 2015; 12:7. PMC: 4417246. DOI: 10.1186/1742-4755-12-7. View

Kaluzna M, Czlapka-Matyasik M, Kompf P, Moczko J, Wachowiak-Ochmanska K, Janicki A . Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2022; 13:20420188211066699. PMC: 8755932. DOI: 10.1177/20420188211066699. View

Chae S, Kim J, Choi Y, Hwang K, Jee B, Ku S . Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod. 2008; 23(8):1924-31. DOI: 10.1093/humrep/den239. View

Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Aliasgharzadeh A, Aliashrafi S, Rezayi N . Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr. 2015; 33(1):157-67. PMC: 4438659. View

Usta A, Avci E, Bulbul C, Kadi H, Adali E . The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2018; 16(1):34. PMC: 5891948. DOI: 10.1186/s12958-018-0351-0. View

Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q . Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria. Int J Endocrinol Metab. 2014; 12(1):e12470. PMC: 3968989. DOI: 10.5812/ijem.12470. View

10.

Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, Sadein B . Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect. 2014; 3(2):206-16. PMC: 3963667. DOI: 10.5681/hpp.2013.024. View

11.

Kalra A, Nair S, Rai L . Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci. 2006; 60(11):447-53. View

12.

Mirdamadi A, Riahinejad S, Varnaseri S . The association between anthropometric parameters and cardiovascular risk indicators in women with polycystic ovarian syndrome. ARYA Atheroscler. 2020; 16(1):39-43. PMC: 7244789. DOI: 10.22122/arya.v16i1.1804. View

13.

Deng Y, Zhang Y, Li S, Zhou W, Ye L, Wang L . Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome. Sci Rep. 2017; 7(1):14156. PMC: 5658378. DOI: 10.1038/s41598-017-14534-2. View

14.

Blank S, McCartney C, Chhabra S, Helm K, Eagleson C, Chang R . Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation. J Clin Endocrinol Metab. 2009; 94(7):2360-6. PMC: 2708962. DOI: 10.1210/jc.2008-2606. View

15.

Tsouma I, Kouskouni E, Demeridou S, Boutsikou M, Hassiakos D, Chasiakou A . Lipid lipoprotein profile alterations in Greek infertile women with polycystic ovaries: influence of adipocytokines levels. In Vivo. 2014; 28(5):935-9. View

16.

Lo J, Yang J, Gunderson E, Hararah M, Gonzalez J, Ferrara A . Risk of Type 2 Diabetes Mellitus following Gestational Diabetes Pregnancy in Women with Polycystic Ovary Syndrome. J Diabetes Res. 2018; 2017:5250162. PMC: 5750496. DOI: 10.1155/2017/5250162. View

17.

Keys A, Fidanza F, KARVONEN M, Kimura N, Taylor H . Indices of relative weight and obesity. J Chronic Dis. 1972; 25(6):329-43. DOI: 10.1016/0021-9681(72)90027-6. View

18.

Shirazi F, Khodamoradi Z, Jeddi M . Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS). BMC Endocr Disord. 2021; 21(1):45. PMC: 7941970. DOI: 10.1186/s12902-021-00710-z. View

19.

Layegh P, Mousavi Z, Farrokh Tehrani D, Parizadeh S, Khajedaluee M . Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients. Int J Reprod Biomed. 2016; 14(4):263-70. PMC: 4918775. View

20.

Qu H, Li Q, Rentfro A, Fisher-Hoch S, McCormick J . The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One. 2011; 6(6):e21041. PMC: 3114864. DOI: 10.1371/journal.pone.0021041. View